Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Breast Cancer is Scopus-indexed (Q2, CiteScore 4.7), WoS SCIE, DOAJ. Published by Korean Breast Cancer Society.
Checked against the index lists dated .
ISSN 1738-6756Verify ISSN ↗2092-9900Verify ISSN ↗
Publisher: Korean Breast Cancer Society
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 173 / 428 | 59th | Q2 |
| Cancer Research | 139 / 233 | 40th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q2, CiteScore 4.7.
Journal of Breast Cancer is Q2 in Oncology (rank 173 of 428) and Q3 in Cancer Research (rank 139 of 233), by CiteScore 2025.
Journal of Breast Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.7, which places it in quartile Q2 at the 59th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.890, quartile Q2, with an H-index of 55.
The publisher lists an article processing charge of about US$500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Breast Cancer is published by Korean Breast Cancer Society. Its print ISSN is 1738-6756 and its online ISSN is 2092-9900.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Breast Cancer has an h-index of 64 and a 2-year mean of 2.15 citations per paper (OpenAlex). Its Scopus CiteScore is 4.7, quartile Q2. On 2-year citations it ranks #179 of 424 Scopus journals in Oncology.
Journal of Breast Cancer published 45 papers in 2025; its busiest recent year was 2020 with 69. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2024–2026), authors are most often from South Korea (61.9%), China (15.3%) and Japan (5.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (2.7 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.